Inactive Instrument
Biondvax Pharmaceuticals Ltd Stock Other OTC
Stocks
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 2021-03-01 |
Uri Ben-Or
DFI | Director of Finance/CFO | 54 | 2006-12-31 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Adi Raviv
BRD | Director/Board Member | 71 | 2020-03-23 |
Samuel Moed
BRD | Director/Board Member | 64 | 2020-03-23 |
Mark Germain
CHM | Chairman | 77 | 2019-09-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 38.98M | |
| +1.68% | +3.55% | +4.86% | +10.97% | 49.42B | |
| +0.72% | +1.93% | +424.51% | +624.25% | 40.34B | |
| +2.54% | +2.84% | +27.06% | -3.62% | 34.01B | |
| +0.31% | +4.16% | +23.87% | +59.76% | 33.56B | |
| -2.09% | -0.80% | +3.56% | +33.56% | 26.84B | |
| -0.63% | +2.85% | - | - | 17.22B | |
| +0.66% | -1.48% | +66.05% | +127.36% | 15.19B | |
| -23.90% | -18.84% | +55.47% | +53.83% | 13.96B | |
| +2.59% | +0.50% | +15.28% | +21.25% | 13.36B | |
| Average | +0.58% | +0.83% | +77.58% | +115.92% | 27.1B | |
| Weighted average by Cap. | +0.77% | +0.90% | +93.37% | +138.87% |
Choose MarketScreener 
